EADV 2020

2020-10-29 - 2020-10-31
Online, Virtual

EADV 2019

2019-10-09 - 2019-10-13
Madrid, Spain

EADO 2019

2019-04-24 - 2019-04-27
Paris, France

AAD 2019

2019-03-03 - 2019-03-05
Washington DC, United States

EADV 2018

2018-09-12 - 2018-09-18
Paris, France

EDC 2018

2018-03-01 - 2018-03-03
Paris, France

EADV 2017

2017-09-13 - 2017-09-17
Geneva, Switzerland

AAD 2017

2017-03-03 - 2017-03-07
Orlando, United States

AAD 2016

2016-03-04 - 2016-03-08
Washington DC, United States
Search in Scientific Content:
Date
Filters:
Psoriasis
6:51

Psoriasis is a systemic disease

Presenter: Paolo Gisondi
EADV 2020
New non-al
6:36

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

Presenter: Julia Gallinger
EADV 2020
New eviden
7:47

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

Presenter: Douglas Maslin
EADV 2020
New Resear
4:08

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

Presenter: Marco Cusini
EADV 2020
New analys...
18:47

New analysis reveals ‘long-hauler’ COVID-19 patients with prolonged skin symptoms - Lessons from the International COVID-19 Dermatology Registry

Presenter: Esther Freeman
EADV 2020
Urban livi
3:59

Urban living decreases skin bacterial diversity and why is it a problem

Presenter: Chris Callewaert
EADV 2020
Contact de
8:04

Contact dermatitis: New allergens

Presenter: Margarida Gonçalo
EADV 2019
Hidradenit
5:28

Hidradenitis suppurativa

Presenter: Hessel van der Zee
EADV 2019
Moderate p
4:27

Moderate psoriasis: a journey towards patient-centred care

Presenter: Jose-Manuel Carrascosa
EADV 2019
Emerging t
5:24

Emerging treatments for onychomycosis

Presenter: Ditte Marie Saunte
EADV 2019
Primay res
4:53

Primay results on acne exposome: real life data

Presenter: Delphine Kerob
EADV 2019
Safety and
8:42

Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata

Presenter: Brett King
EADV 2019
Highlights
2:07

Highlights of the laser session at EADV 2019

Presenter: Pablo Boixeda
EADV 2019
Internatio
4:56

International landscape of therapies in CTCL

Presenter: Pietro Quaglino
EADO 2019
Molecular
6:010

Molecular resistance to targeted therapy, from bench to bedside

Presenter: Grant McArthur
EADO 2019
When instr...
2:23

When instruments are not enough, clinical clues are needed 

Presenter: Aimilios Lallas
EADO 2019